QSAR Study of 4-Aryl-4H-Chromenes as a New Series of Apoptosis Inducers Using Different Chemometric Tools

Chemical Biology and Drug Design

Volumn 79, Issue 4, 2012, Pages 442-458

  Khoshneviszadeh, Mehdi ^a,b   Edraki, Najmeh ^a,b   Miri, Ramin ^a   Foroumadi, Alireza ^b   Hemmateenejad, Bahram ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY   (Iran)

Author keywords

Apoptosis inducing activity; Cancer cell line; Chemometrics; Chromenes; Quantitative structure activity relationship

Indexed keywords

CHROMENE DERIVATIVE; MX 58151; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHEMOMETRIC ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DRUG MECHANISM; FACTORIAL ANALYSIS; GENETIC ALGORITHM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG NON SMALL CELL CANCER; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ALGORITHMS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOPYRANS; CELL LINE, TUMOR; HUMANS; LINEAR MODELS; MODELS, STATISTICAL; NEOPLASMS; PRINCIPAL COMPONENT ANALYSIS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84858797062     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2011.01284.x     Document Type: Article

References (44)

1. Lowe S.W., Lin A.W. (2000) Apoptosis in cancer. Carcinogenesis;21:485-495.
2. Reed J.C., Tomaselli K.J. (2000) Drug discovery opportunities from apoptosis research. Curr Opin Biotechnol;11:586-592.
3. Earnshaw W.C., Martins L.M., Kaufmann S.H. (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem;68:383-424.
4. Kemnitzer W., Kasibhatla S., Jiang S., Zhang H., Zhao J., Jia Sh., Xu L. et al. (2005) Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positions. Bioorg Med Chem Lett;15:4745-4751.
5. Thompson C.B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science;267:1456-1462.
6. Herr I., Debatin K.M. (2001) Cellular stress response and apoptosis in cancer therapy. Blood;98:2603-2614.
7. Rich T., Allen R.L., Wyllie A.H. (2000) Defying death after DNA damage. Nature;407:777-783.
8. Kanthou C., Tozer G.M. (2002) The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells. Blood;99:2060-2069.
9. Thorpe P.E., Chaplin D.J., Blakey D.C. (2003) The first international conference on vascular targeting: meeting overview. Cancer Res;63:1144-1147.
10. Jordan A., Hadfield J.A., Lawrence N.J., McGown A.T. (1998) Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med Res Rev;18:259-296.
11. Li Q., Sham H., Rosenburg S. (1999) Antimitotic agents. Annu Rev Med Chem;34:139-148.
12. Haggarty S.J., Mayer T.U., Miyamoto D.T., Fathi R., King R.W., Mitchison T.J., Schreiber S.L. (2000) Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. Chem Biol;7:275-286.
13. Hadjipavlou-Litina D. (1998) Review, reevaluation, and new results in quantitative structure-activity studies of anticonvulsants. Med Res Rev;18:91-119.
14. Gramatica P., Papa E. (2003) QSAR modeling of bioconcentration factor by theoretical molecular descriptorsQSAR. Comb Sci;22:374-385.
15. Hansch C., Kurup A., Garg R., Gao H. (2001) Chem-bioinformatics and QSAR: a review of QSAR lacking positive hydrophobic terms. Chem Rev;101:619-672.
16. Horvath D., Mao B. (2003) Neighborhood behavior. Fuzzy molecular descriptors and their influence on the relationship between structural similarity and property similarity. QSAR Comb Sci;22:498-509.
17. Putta S., Eksterowicz J., Lemmen C., Stanton R. (2003) A novel subshape molecular descriptor. J Chem Inf Comput Sci;43:1623-1635.
18. Gupta S., Singh M., Madan A.K. (1999) Superpendentic index: a novel topological descriptor for predicting biological activity. J Chem Inf Comput Sci;39:272-277.
19. Consonni V., Todeschini R., Pavan M. (2002) Structure/response correlations and similarity/diversity analysis by GETAWAY descriptors. 2. Application of the novel 3D molecular descriptors to QSAR/QSPR studies. J Chem Inf Comput Sci;42:693-705.
20. Hansch C., Bonavida B., Jazirehi A., Cohen J., Milliron C., Kurup A. (2003) A Quantitative structure-activity relationships of phenolic compounds causing apoptosis. Bioorg Med Chem;11:617-620.
21. Hansch C., Jazirehi A., Mekapati S., Garg R., Bonavida B. (2003) QSAR of apoptosis induction in various cancer cells. Bioorg Med Chem;11:3015-3019.
22. Selassie C.D., Kapur S., Verma R.P., Rosario M. (2005) Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study. J Med Chem;48:7234-7242.
23. Afantitis A., Melagraki G., Sarimveis H., Koutentis P.A., Markopoulos J., Igglessi-Markopoulou O. (2006) A novel QSAR model for predicting induction of apoptosis by 4-aryl-4H-chromenes. Bioorg Med Chem;14:6686-6694.
24. Fatemi M.H., Gharaghani S. (2007) A novel QSAR model for prediction of apoptosis-inducing activity of 4-aryl-4H-chromenes based on support vector machine. Bioorg Med Chem;15:7746-7754.
25. Kemnitzer W., Drewe J., Jiang S., Zhang H., Wang Y., Zhao J., Jia S. et al. (2004) Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. J Med Chem;47:6299-6310.
26. Hemmateenejad B., Safarpour M.A., Miri R., Taghavi F. (2004) Application of ab initio theory to QSAR study of 1, 4-dihydropyridine-based calcium channel blockers using GA-MLR and PC-GA-ANN procedures. J Comput Chem;25:1495-1503.
27. Hansch C., Leo A., Taft R.W. (1991) A survey of Hammelt substituent constants and resonance and field parameters. Chem Rev;91:165-195.
28. Darlington R.B. (1990) Regression and Linear Models. New York: McGrawHill.
29. Leonard J.T., Roy K. (2006) QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques. Bioorg Med Chem;14:1039-1046.
30. Franke R. (1984) Theoretical Drug Design Methods. Amsterdam: Elsevier.
31. Franke R., Gruska A. (1995) Chemometrics methods in molecular design. In: van Waterbeemd H., editor, Methods and Principles in Medicinal Chemistry. Weinheim: VCH; p. 113-119.
32. Sharaf M.A., Illman D.L., Kowalski B.R. (1986) Chemometrics. New York: Wiley.
33. Kubinyi H. (1995) In: Wolff M.E., editor, Burger's Medicinal Chemistry and Drug Discovery, 5th edn, Vol. I, New York: Wiley; p. 507.
34. Cho S.J., Hermsmeier M.A. (2002) Genetic algorithm guided selection: variable selection and subset selection. J Chem Inf Comput Sci;42:927-936.
35. Ahamd S., Gromoha M.M. (2003) Design and training of a neural network for predicting the solvent accessibility of proteins. J Comput Chem;24:1313-1320.
36. Fan Y., Shi L.M., Kohn K.W., Pommier Y., Weinstein J.N. (2001) Quantitative structure-antitumor activity relationships of camptothecin analogues: cluster analysis and genetic algorithm-based studies. J Med Chem;44:3254-3263.
37. Leardi R. (2001) Genetic algorithms in chemometrics and chemistry: a review. J Chemom;15:559-569.
38. Edraki N., Hemmateenejad B., Miri R., Khoshneviszadeh M. (2007) QSAR study of phenoxypyrimidine derivatives as potent inhibitors of p38 kinase using different chemometric tools. Chem Biol Drug Des;70:530-539.
39. Hemmateenejad B. (2004) Optimal QSAR analysis of the carcinogenic activity of a large set of drugs using correlation ranking and genetic algorithm-based PCR. J Chemom;18:475-485.
40. Olah M., Bologa C., Oprea T.I. (2004) An automated PLS search for biologically relevant QSAR descriptors. J Comput Aided Mol Des;18:437-449.
41. Erikson L., Johansson E., Kettaneh-Wold N., Wold S. (2001) Multi- and Megavariate. Umea: Umetrics Academy.
42. Gramatica P. (2007) Principles of QSAR models validation: internal and external. QSAR Comb Sci;26:694-701.
43. Free S.M.J.R., Wilson J.W. (1964) A mathematical contribution to structure-activity studies. J Med Chem;7:395-399.
44. Hemmateenejad B., Yazdani M. (2009) QSPR models for half-wave reduction potential of steroids: a comparative study between feature selection and feature extraction from subsets of or entire set of descriptors. Anal Chim Acta;16:27-35.